Cytokine Protein Family
    6.
    发明授权
    Cytokine Protein Family 有权
    细胞因子蛋白家族

    公开(公告)号:US08124065B2

    公开(公告)日:2012-02-28

    申请号:US13028101

    申请日:2011-02-15

    IPC分类号: A61K38/00 A61K45/00 C07K14/00

    CPC分类号: C07K14/56 C12Q2600/158

    摘要: The present invention relates to polynucleotide and polypeptide molecules for zcyto20, zcyto21, zcyto22, zycto24, and zcyto25 proteins which are most closely related to interferon-α at the amino acid sequence level. The receptor for this protein family is a class II cytokine receptor. The present invention includes methods of reducing viral infections and increasing monocyte counts. The present invention also includes antibodies to the zcyto20 polypeptides, and methods of producing the polynucleotides and polypeptides.

    摘要翻译: 本发明涉及与氨基酸序列水平上与干扰素-α最密切相关的zcyto20,zcyto21,zcyto22,zycto24和zcyto25蛋白的多核苷酸和多肽分子。 该蛋白家族的受体是II类细胞因子受体。 本发明包括减少病毒感染和增加单核细胞计数的方法。 本发明还包括针对zcyto20多肽的抗体,以及产生多核苷酸和多肽的方法。

    USE OF TRUNCATED CYSTEINE IL28 AND IL29 MUTANTS TO TREAT CANCERS AND AUTOIMMUNE DISORDERS
    7.
    发明申请
    USE OF TRUNCATED CYSTEINE IL28 AND IL29 MUTANTS TO TREAT CANCERS AND AUTOIMMUNE DISORDERS 有权
    使用截短的CYSTEINE IL28和IL29突变体治疗癌症和自身免疫性疾病

    公开(公告)号:US20110177024A1

    公开(公告)日:2011-07-21

    申请号:US13042210

    申请日:2011-03-07

    申请人: Paul O. Sheppard

    发明人: Paul O. Sheppard

    IPC分类号: A61K38/20 A61P37/06

    摘要: Methods for treating patients with cancer and autoimmune disorders using IL-28 and IL-29 molecules. The IL-28 and IL-29 molecules include polypeptides that have homology to the human IL-28 or IL-29 polypeptide sequence and proteins fused to a polypeptide with IL-28 and IL-29 functional activity. The molecules can be used as a monotherapy or in combination with other known cancer and/or autoimmune therapeutics.

    摘要翻译: 使用IL-28和IL-29分子治疗患有癌症和自身免疫疾病的患者的方法。 IL-28和IL-29分子包括与人IL-28或IL-29多肽序列具有同源性的多肽,以及与具有IL-28和IL-29功能活性的多肽融合的蛋白质。 分子可以用作单一疗法或与其它已知的癌症和/或自身免疫治疗剂组合使用。

    USE OF TRUNCATED CYSTEINE IL28 AND IL29 MUTANTS TO TREAT CANCERS AND AUTOIMMUNE DISORDERS
    8.
    发明申请
    USE OF TRUNCATED CYSTEINE IL28 AND IL29 MUTANTS TO TREAT CANCERS AND AUTOIMMUNE DISORDERS 审中-公开
    使用截短的CYSTEINE IL28和IL29突变体治疗癌症和自身免疫性疾病

    公开(公告)号:US20100298230A1

    公开(公告)日:2010-11-25

    申请号:US12611067

    申请日:2009-11-02

    申请人: Paul O. Sheppard

    发明人: Paul O. Sheppard

    摘要: Methods for treating patients with cancer and autoimmune disorders using IL-28 and IL-29 molecules. The IL-28 and IL-29 molecules include polypeptides that have homology to the human IL-28 or IL-29 polypeptide sequence and proteins fused to a polypeptide with IL-28 and IL-29 functional activity. The molecules can be used as a monotherapy or in combination with other known cancer and/or autoimmune therapeutics.

    摘要翻译: 使用IL-28和IL-29分子治疗患有癌症和自身免疫疾病的患者的方法。 IL-28和IL-29分子包括与人IL-28或IL-29多肽序列具有同源性的多肽,以及与具有IL-28和IL-29功能活性的多肽融合的蛋白质。 分子可以用作单一疗法或与其它已知的癌症和/或自身免疫治疗剂组合使用。